Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis
| Status: | Completed |
|---|---|
| Conditions: | Arthritis, Rheumatoid Arthritis |
| Therapuetic Areas: | Rheumatology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 4/21/2016 |
| Start Date: | October 2007 |
| End Date: | October 2008 |
The goal of the project is to study the risk of coccidioidomycosis (valley fever) in
patients receiving anti-TNF and other biologic agents for inflammatory arthritis in Tucson,
Arizona.
patients receiving anti-TNF and other biologic agents for inflammatory arthritis in Tucson,
Arizona.
Retrospective chart review of all patients with an inflammatory arthritis seen at the
University Rheumatology clinic since January 2000.
University Rheumatology clinic since January 2000.
Inclusion Criteria:
- All active patients with an inflammatory arthritis seen at the University of Arizona
from January 2000
Exclusion Criteria:
We found this trial at
1
site
Click here to add this to my saved trials
